drugset / Trial / NCT07441421

Perioperative Multimodal Analgesia for Supratentorial Craniotomy

NCT07441421 ↗

Not yet recruiting 2000 enrolled Beijing Tiantan Hospital
RandomizedFactorialTriple-blindPrevention

Summary

This randomized clinical trial aims to evaluate the effectiveness of scalp nerve blocks and dexmedetomidine in reducing opioid use and preventing postoperative delirium in patients undergoing supratentorial brain tumor surgery. A total of 2000 patients will be randomly assigned to one of four groups, receiving either active treatments, placebos, or their combinations. The main outcome measured will be the amount of opioid pain medication needed after surgery.

Timeline

Start
2026-03-01
Primary completion
2027-12-31
Completion
2027-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 0.05 ug/kg Intravenous

Indications